Assessment of the licensing and patenting practices of UK's leading medical research institutions

Sarai Keestra made this Freedom of Information request to University of Leicester

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

The request was successful.

Dear University of Leicester,

The FOI request below is being filed on behalf of UAEM-UK. Please note that the answers to these questions will be used to determine the university’s score in the forthcoming Global Health Ranking of leading UK universities by Universities Allied for Essential Medicines (UAEM) UK.

We encourage you to read this background briefing before compiling your response:
https://docs.google.com/document/d/1GMzH...

Thank you very much for your time & best wishes,
Sarai Keestra - Universities Allied for Essential Medicines UK

START FOI

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions

Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/jr6s6fm]

Patent: A form of intellectual property (IP) rights protection, whereby a government grants to the inventor, the right to stop others from making, using or selling the product without their permission for a limited period.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Licence: Contracts that transfer IP rights from the owner of the rights to a third party for use.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’ Source: WHO, available online [http://www.who.int/health-technology-ass...

Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the past year AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide an Excel spreadsheet with all the health technologies PATENTED by the university in the past year AND specify which countries they were patented in.

Q4.Has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?
- Contributed sample clauses to the AUTM Global Health Toolkit
- Published an article, guidance, or other literature on access licensing practices
- Formally presented on access licensing practices at an academic or professional event, or at another university
- Informally shared or discussed access licensing practices with administrators at other universities
- Other
- None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the past year to improve access to the technologies they license in low- and middle-income settings?

END FOI

Yours faithfully,

Sarai Keestra

15th October 2018

Dear Sarai,

I write to acknowledge receipt of your request, dated 9th October 2018. Please note we are processing your request under the provisions of the Freedom of Information Act 2000.

Also, please note the effective date of the request, i.e. date of receipt of your request by the University of Leicester for processing, is 9th October 2018 and that the latest date by which the University must respond under the terms of the Freedom of Information Act 2000 is 6th November 2018.

I will arrange for the information to which you are entitled under the Freedom of Information Act 2000 to be supplied to you as soon as reasonably possible, and in any event within the period set out by the Act.

Please do not hesitate to contact me if you have any queries regarding your request.

Regards,

Claudia Perdomo-Pelaez
Senior Information Assurance Officer
Information Assurance Services,
University of Leicester, University Road, Leicester, LE1 7RH, UK
t: +44 (0)116 229 7345
e: [email address]
w: www.le.ac.uk

show quoted sections

Dear IAS,

It has been pointed out to me that the link to the background briefing in our FOI request was broken. Please accept my sincerest apologies for this inconvenience. This link should now be working: https://docs.google.com/document/d/1GMzH...

Yours sincerely,

Sarai Keestra

1 Attachment

Dear Sarai,

I write on behalf of the University of Leicester in response to your request, dated 9th October 2018 made under the provisions of the Freedom of Information Act 2000. Our response is as follows

Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

The university does not have specific commitments or policy documents, as these are taken into consideration case by case. However, we have an overarching IP policy, please find attached.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the past year AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.

Health Technology Licensed Country of Licensing Type of License (Exclusive or Non- Exclusive)
Hybrid Optical Gamma Camera USA, Canada, UK, Italy, France
Germany, Spain, Australia. Exclusive

Q3. Please provide an Excel spreadsheet with all the health technologies PATENTED by the university in the past year AND specify which countries they were patented in.

Title Countries
An improved hybridisation selection based targeted DNA enrichment technology Europe, United States.
Automatic Measurement and Characterisation of Urine Flow in Patients Europe, United States, China, Australia, Japan
Evidence Collection Kit for Sexual Assault PCT
Developing brain penetrant inhibitors United Kingdom
The Lithocatheter Europe, United States.
CSN5 Polypeptides France, United Kingdom, Germany.
Lyme disease PCT

Q4.Has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

- Contributed sample clauses to the AUTM Global Health Toolkit
- Published an article, guidance, or other literature on access licensing practices
- Formally presented on access licensing practices at an academic or professional event, or at another university (Ticked)
- Informally shared or discussed access licensing practices with administrators at other universities (Ticked)
- Other
- None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the past year to improve access to the technologies they license in low- and middle-income settings?

The University had been promoting our technologies online via a professional technology portal, called ‘IN part https://in-part.com/’ to which any company can register for free.

If you have any concerns or wish to complain or appeal about any aspect of this response then in the first instance please contact the University's Data Protection Officer (Liz Taoudi: 0116 229 7640, [email address])

Please be aware that it is also your legal right under Section 50 of the Freedom of Information Act, to apply to the Information Commissioner for a decision whether a request for information made to the University has been dealt with in accordance with the provisions of the Act. It should be noted that there is a requirement that there will be no undue delay in making the application and there is an expectation that the complainant will have exhausted the University's internal complaints procedure.

Complaints to the Information Commissioner should be addressed to:

FoI Compliance Team (Complaints)
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

I hope you find this response helpful. Please don't hesitate to contact me if you have any queries regarding the above.

Regards,

Claudia Perdomo-Pelaez
Senior Information Assurance Officer
Information Assurance Services,
University of Leicester, University Road, Leicester, LE1 7RH, UK
t: +44 (0)116 229 7345
e:  [email address
w: www.le.ac.uk

show quoted sections